APA

Dietrich P. Y., Walker P. R., Quiquerez A. L., Perrin G., Dutoit V., Liénard D., Guillaume P., Cerottini J. C., Romero P. & Valmori D. (20010419). Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires. : Cancer research.

Chicago

Dietrich P Y, Walker P R, Quiquerez A L, Perrin G, Dutoit V, Liénard D, Guillaume P, Cerottini J C, Romero P and Valmori D. 20010419. Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires. : Cancer research.

Harvard

Dietrich P. Y., Walker P. R., Quiquerez A. L., Perrin G., Dutoit V., Liénard D., Guillaume P., Cerottini J. C., Romero P. and Valmori D. (20010419). Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires. : Cancer research.

MLA

Dietrich P Y, Walker P R, Quiquerez A L, Perrin G, Dutoit V, Liénard D, Guillaume P, Cerottini J C, Romero P and Valmori D. Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires. : Cancer research. 20010419.